Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

Nonpeptide alphav/beta3 antagonist effective in rabbit model of neointima formation

Nov. 12, 1997

Potent and selective fibrinogen receptor antagonist presented by DuPont Merck

Nov. 12, 1997

C921-78: a new factor Xa antagonist prevents thrombosis with reduced blood loss

Nov. 12, 1997

Fibrinogen receptor occupancy, antiplatelet activity and safety of lefradafiban

Nov. 10, 1997

Lamifiban efficacy demonstrated in PARAGON trial

Nov. 10, 1997

Preclinical and clinical profile of Searle's fibrinogen antagonist

Nov. 10, 1997

TP-9201 covered by new U.S. patent

Nov. 10, 1997

Fibrinogen antagonists from Merck & Co.

Nov. 10, 1997

Spotlight on thrombin inhibitors

Nov. 10, 1997

ReoPro cleared in U.S. for expanded labeling

Nov. 7, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...